Weihai Baihe Biology Technological Co., Ltd.

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: CNE100005RB6

CNY

42.26

1.26 (3.07%)

Dec 15

SHG

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Weihai Baihe Biology Technological Co., Ltd.

Why is Weihai Baihe Biology Technological Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 6.05% and Operating profit at -7.31% over the last 5 years

Negative results in Mar 25

NET PROFIT(HY) At CNY 57.85 MM has Grown at -23.08%
ROCE(HY) Lowest at 8.77%
RAW MATERIAL COST(Y) Grown by 8.1% (YoY)

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Weihai Baihe Biology Technological Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Weihai Baihe Biology Technological Co., Ltd.

7.2%

0.89

38.18%

China Shanghai Composite

12.36%

0.86

14.45%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

6.05%

EBIT Growth (5y)

-7.31%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.68

Sales to Capital Employed (avg)

0.53

Tax Ratio

13.53%

Dividend Payout Ratio

33.86%

Pledged Shares

Institutional Holding

ROCE (avg)

35.53%

ROE (avg)

10.04%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.81

EV to EBIT

1.92

EV to EBITDA

1.51

EV to Capital Employed

0.41

EV to Sales

0.28

PEG Ratio

Dividend Yield

ROCE (Latest)

21.49%

ROE (Latest)

7.66%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-5What is not working for the Company

NET PROFIT(HY)

At CNY 57.85 MM has Grown at -23.08%

ROCE(HY)

Lowest at 8.77%

RAW MATERIAL COST(Y)

Grown by 8.1% (YoY

Here's what is not working for Weihai Baihe Biology Technological Co., Ltd.

Net Profit

At CNY 57.85 MM has Grown at -23.08%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Raw Material Cost

Grown by 8.1% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales